T1	Participants 74 109	rhinoconjunctivitis quality of life
T2	Participants 141 169	allergic rhinoconjunctivitis
T3	Participants 674 814	adult subjects with a history of moderate-severe grass pollen induced rhinoconjunctivitis inadequately controlled by symptomatic medications
T4	Participants 816 918	Subjects received 3 years of grass AIT (n = 157) or placebo (n = 126), followed by 1 year of follow-up
